Literature DB >> 21574975

Water-filtered infrared A for the treatment of chronic venous stasis ulcers of the lower legs at home: a randomized controlled blinded study.

H Schumann1, T Calow, S Weckesser, M L Müller, G Hoffmann.   

Abstract

BACKGROUND: Water-filtered infrared A (wIRA) radiation can improve the healing of acute and chronic wounds both by thermal and thermic as well as by nonthermal and nonthermic effects. wIRA increases tissue temperature, oxygen partial pressure and perfusion.
OBJECTIVES: Investigation of the influence of wIRA on chronic venous stasis ulcers in an investigator-initiated, randomized, controlled, blinded study.
METHODS: Fifty-one patients with nonhealing chronic venous stasis ulcers of the lower legs were treated with compression therapy, wound cleansing, nonadhesive wound dressings and 30 min irradiation [wIRA + visible light (VIS) or VIS alone], predominantly at home, five times per week over 9 weeks and an additional 4 weeks without irradiation.
RESULTS: Compared with the control group with VIS alone, the group with wIRA + VIS showed better wound healing [after 9 weeks 85 vs. 67·5 on a 0-100 visual analogue scale (VAS), median difference 15, 95% confidence interval (CI) 3-30, P = 0·012], a higher percentage of patients with a healing trend [after 9 weeks 21 of 25 (84%) vs. 13 of 26 (50%), P = 0·023], better granulation (after 9 weeks 90 vs. 80 on a 0-100 VAS, median difference 10, 95% CI 0-30, P = 0·036), a trend to less exudation (after 5 weeks 30 vs. 55 on a 0-100 VAS, P = 0·075) and to faster reduction of the wound area (after 7 weeks 39% vs. 19·5% reduction of wound area, median difference 20·5%, 95% CI -4-49%, P = 0·10; for wounds with an initial area < 10 cm(2): after 13 weeks 92% vs. 47% reduction of wound area, median difference 30%, 95% CI 0-68%, P = 0·11). The main variable 'Integral of relative ulcer area for each individual patient over time, standardized to an initial size of 1' did not reach significance. The application of wIRA at home was easily manageable.
CONCLUSIONS: For the treatment of chronic venous stasis ulcers, the application of wIRA combined with phlebological therapy, compression therapy and wound dressing can be useful and can be recommended.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21574975     DOI: 10.1111/j.1365-2133.2011.10410.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  Novel Broad-Spectrum Antimicrobial Photoinactivation of In Situ Oral Biofilms by Visible Light plus Water-Filtered Infrared A.

Authors:  L Karygianni; S Ruf; M Follo; E Hellwig; M Bucher; A C Anderson; K Vach; A Al-Ahmad
Journal:  Appl Environ Microbiol       Date:  2014-09-19       Impact factor: 4.792

Review 2.  [Water-filtered infrared-A (wIRA) promotes wound healing].

Authors:  R Winkel; G Hoffmann; R Hoffmann
Journal:  Chirurg       Date:  2014-11       Impact factor: 0.955

Review 3.  Heat for wounds - water-filtered infrared-A (wIRA) for wound healing - a review.

Authors:  Gerd Hoffmann; Mark Hartel; James B Mercer
Journal:  Ger Med Sci       Date:  2016-06-29

4.  Balneotherapy for chronic venous insufficiency.

Authors:  Melissa Andreia de Moraes Silva; Luis Cu Nakano; Lígia L Cisneros; Fausto Miranda
Journal:  Cochrane Database Syst Rev       Date:  2019-08-26

5.  Antimicrobial Photoinactivation Using Visible Light Plus Water-Filtered Infrared-A (VIS + wIRA) and Hypericum Perforatum Modifies In Situ Oral Biofilms.

Authors:  Andreas Vollmer; Ali Al-Ahmad; Aikaterini Argyropoulou; Thomas Thurnheer; Elmar Hellwig; Thomas Attin; Kirstin Vach; Annette Wittmer; Kerry Ferguson; Alexios Leandros Skaltsounis; Lamprini Karygianni
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

6.  Pain in persons with chronic venous leg ulcers: A systematic review and meta-analysis.

Authors:  Lena Leren; Edda Johansen; Hilde Eide; Ragnhild S Falk; Lene K Juvet; Tone M Ljoså
Journal:  Int Wound J       Date:  2020-01-03       Impact factor: 3.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.